Screener
Krystal Biotech, Inc. KRYS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s free cash flow?
- Krystal Biotech, Inc. (KRYS) reported free cash flow of $73.23M in Q1 2026.
- How has Krystal Biotech, Inc.'s free cash flow changed year-over-year?
- Krystal Biotech, Inc.'s free cash flow increased by 195.7% year-over-year, from $24.77M to $73.23M.
- What is the long-term trend for Krystal Biotech, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s free cash flow has grown at a 12.9% compound annual growth rate (CAGR), from -$116.27M to $188.91M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Krystal Biotech, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude